waypoint wealth counsel Acquires 13,085 Shares of Centene Corporation $CNC

waypoint wealth counsel increased its position in shares of Centene Corporation (NYSE:CNCFree Report) by 98.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 26,313 shares of the company’s stock after purchasing an additional 13,085 shares during the period. waypoint wealth counsel’s holdings in Centene were worth $1,083,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of CNC. WPG Advisers LLC boosted its stake in Centene by 44.5% in the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after buying an additional 282 shares in the last quarter. Prime Capital Investment Advisors LLC boosted its stake in Centene by 5.7% in the 4th quarter. Prime Capital Investment Advisors LLC now owns 5,975 shares of the company’s stock valued at $246,000 after buying an additional 324 shares in the last quarter. Burney Co. boosted its stake in Centene by 3.8% in the 4th quarter. Burney Co. now owns 9,053 shares of the company’s stock valued at $373,000 after buying an additional 331 shares in the last quarter. Versant Capital Management Inc boosted its stake in Centene by 11.6% in the 3rd quarter. Versant Capital Management Inc now owns 3,421 shares of the company’s stock valued at $122,000 after buying an additional 355 shares in the last quarter. Finally, Snowden Capital Advisors LLC boosted its stake in Centene by 8.0% in the 2nd quarter. Snowden Capital Advisors LLC now owns 5,073 shares of the company’s stock valued at $275,000 after buying an additional 374 shares in the last quarter. 93.63% of the stock is currently owned by institutional investors.

Centene Trading Up 3.1%

Shares of NYSE:CNC opened at $40.12 on Thursday. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.87. The firm has a market cap of $19.73 billion, a price-to-earnings ratio of -2.94, a PEG ratio of 0.87 and a beta of 0.59. Centene Corporation has a 12 month low of $25.08 and a 12 month high of $64.15. The company’s fifty day simple moving average is $38.20 and its 200 day simple moving average is $39.05.

Centene (NYSE:CNCGet Free Report) last posted its quarterly earnings data on Friday, February 6th. The company reported ($1.19) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.22) by $0.03. The business had revenue of $49.73 billion during the quarter, compared to the consensus estimate of $48.41 billion. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.Centene’s quarterly revenue was up 21.9% on a year-over-year basis. During the same period last year, the company earned $0.80 earnings per share. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, research analysts forecast that Centene Corporation will post 3.01 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have commented on CNC shares. Mizuho set a $41.00 price target on shares of Centene and gave the company a “neutral” rating in a report on Tuesday, March 10th. Jefferies Financial Group reissued a “hold” rating and issued a $39.00 price target (up from $37.00) on shares of Centene in a report on Monday. JPMorgan Chase & Co. lowered their price target on shares of Centene from $45.00 to $41.00 and set a “neutral” rating for the company in a report on Thursday, March 19th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $41.00 price target on shares of Centene in a research note on Monday, February 9th. Finally, Wells Fargo & Company set a $44.00 price target on Centene and gave the company an “equal weight” rating in a research note on Wednesday, February 18th. Three investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $42.00.

View Our Latest Analysis on CNC

About Centene

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

Featured Stories

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.